BARCLAYS PLC - ADAPTIMMUNE THERAPEUTICS PLC ownership

ADAPTIMMUNE THERAPEUTICS PLC's ticker is ADAP and the CUSIP is 00653A107. A total of 69 filers reported holding ADAPTIMMUNE THERAPEUTICS PLC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of ADAPTIMMUNE THERAPEUTICS PLC
ValueSharesWeighting
Q3 2023$39
-15.2%
50,0610.0%0.00%
Q2 2023$46
-100.0%
50,061
-85.3%
0.00%
Q3 2022$366,000
-14.9%
340,068
+34.6%
0.00%
Q2 2022$430,000252,682
+2297009.1%
0.00%
Q3 2021$011
-77.6%
0.00%
Q2 2021$0
-100.0%
49
-99.4%
0.00%
Q1 2021$43,0000.0%8,189
+2.5%
0.00%
Q4 2020$43,000
-27.1%
7,988
+7.9%
0.00%
Q3 2020$59,000
-20.3%
7,4000.0%0.00%
Q2 2020$74,000
+270.0%
7,4000.0%0.00%
Q1 2020$20,000
+1900.0%
7,400
+1306.8%
0.00%
Q4 2019$1,000
-50.0%
526
-68.0%
0.00%
Q3 2019$2,000
-50.0%
1,643
+88.6%
0.00%
Q1 2019$4,000
+100.0%
871
+221.4%
0.00%
Q4 2018$2,000
+100.0%
271
+367.2%
0.00%
Q3 2018$1,000
-99.8%
58
-99.8%
0.00%
Q2 2018$417,000
+3.5%
35,111
-2.3%
0.00%
Q1 2018$403,000
+72.2%
35,951
+2.4%
0.00%
Q4 2017$234,000
-24.0%
35,100
-6.6%
0.00%
Q3 2017$308,00037,6000.00%
Other shareholders
ADAPTIMMUNE THERAPEUTICS PLC shareholders Q1 2019
NameSharesValueWeighting ↓
NEA Management Company, LLC 15,832,611$68,080,0003.54%
Matrix Capital Management Company, LP 28,000,000$120,400,0003.21%
Virtus ETF Advisers LLC 50,655$218,0000.46%
TFG Asset Management GP Ltd 500,000$2,150,0000.27%
Rock Springs Capital Management LP 800,000$3,440,0000.13%
Orbimed Advisors 1,350,655$5,808,0000.09%
Vident Investment Advisory, LLC 289,340$1,244,0000.07%
WS MANAGEMENT LLLP 185,537$798,0000.05%
Rathbones Group PLC 285,722$1,229,0000.04%
Tekla Capital Management LLC 228,496$983,0000.04%
View complete list of ADAPTIMMUNE THERAPEUTICS PLC shareholders